{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098758","form_type":"8-K","ticker":"ASRT","cik":"0001808665","company_name":"Assertio Holdings, Inc.","filed_at":"2025-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.534340+00:00","generated_at":"2026-05-17T04:05:38.254016+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Assertio, Hanmi amend ROLVEDON supply agreement; price cut mid-single digits","bullets":["Mid-single-digit price reduction on ROLVEDON drug substance from Hanmi, fixed through license term.","Supplier may request price increases from 2028 if costs rise above threshold.","Per-gram pricing decreases if global ROLVEDON volume exceeds unmet threshold.","Spectrum must provide annual forecast; at least 50% of forecasted orders binding.","No minimum purchase requirements; Spectrum may negotiate lower price if process cuts costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098758","json":"https://secwatch.observer/filing/0001104659-25-098758.json","markdown":"https://secwatch.observer/filing/0001104659-25-098758.md","text":"https://secwatch.observer/filing/0001104659-25-098758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/0001104659-25-098758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/tm2528497d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:05:38.254016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}